Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Surgical Oncology · Gallbladder and Extrahepatic Biliary Tract Carcinoma

Surgical Treatment Options and the Transplant Protocol

At a Glance

Surgery is the primary curative treatment for gallbladder and bile duct cancers. The specific procedure depends on the tumor's location and may involve removing parts of the liver or pancreas. Achieving clear margins (R0) and preserving enough healthy liver tissue are critical for long-term success.

Surgery is the primary path toward a cure for gallbladder and bile duct cancers. Because of the complex way these ducts weave through the liver and near the pancreas, these operations are among the most intricate in all of medicine. The goal is always an R0 resection—the complete removal of all visible and microscopic cancer [1][2].

Tailoring the Surgery to the Subtype

The type of surgery you need depends entirely on where the “blueprint” of the tumor is located [3].

  • Gallbladder Cancer (GBC): Surgeons usually perform a radical cholecystectomy. This is more than just removing the gallbladder; it often includes removing a “wedge” of the liver (segments 4b and 5) and nearby lymph nodes to ensure no hidden cancer cells remain [1][4].
  • Perihilar Cholangiocarcinoma (pCCA): Because these tumors sit at the “fork” of the liver ducts, surgery often involves a major hepatectomy (removing a large portion of the liver) along with the bile ducts and the caudate lobe (a small, deep part of the liver) [5].
  • Distal Cholangiocarcinoma (dCCA): Since these tumors are near the bottom of the duct, they usually require a Whipple procedure (pancreatoduodenectomy). This involves removing the head of the pancreas, part of the small intestine, and the bile duct [3].
  • (For completeness: Intrahepatic Cholangiocarcinoma (iCCA) typically requires a partial hepatectomy (liver resection) depending on where the mass is inside the liver, often without needing to remove the extrahepatic bile ducts).

The Safety Check: Future Liver Remnant (FLR)

If a surgeon needs to remove a large piece of your liver, they must calculate the Future Liver Remnant (FLR). This is the amount of healthy liver that will be left behind after the tumor is gone [6].

  • Why it matters: The liver is the body’s chemical factory. If the FLR is too small (usually less than 25–30% for a healthy liver, or 40% if the liver is stressed), you risk post-hepatectomy liver failure [6][7].
  • Growing the Liver: If your FLR is too small, doctors can perform a Portal Vein Embolization (PVE). This procedure blocks blood flow to the “sick” part of the liver, tricking the “healthy” part into growing larger over several weeks so it is big enough for you to survive the surgery [8][9].

The Mayo Clinic Transplant Protocol

For some patients with perihilar cholangiocarcinoma whose tumors cannot be removed by standard surgery, a liver transplant may be an option. This is a highly specialized path known as the Mayo Clinic Protocol [10].

  1. Strict Eligibility: Not every patient is a candidate. The tumor must be a certain size and cannot have spread outside the bile ducts [10].
  2. Neoadjuvant Therapy: Before the transplant, patients undergo intense chemoradiation (chemotherapy and radiation). This “test of time” helps ensure the cancer is stable and hasn’t spread elsewhere [10][11].
  3. Staging Laparotomy: Before the transplant can proceed, surgeons perform a “look-in” surgery (laparotomy) to check the lymph nodes and abdominal lining. If any cancer is found there, the transplant is canceled because it would not be successful [10].
  4. The Result: For those who complete the protocol, the 5-year survival rate is approximately 52%, providing hope for cases once considered untreatable [10].

The Importance of R0 Margins

In every biliary surgery, the “R” status is the most important predictor of long-term success. An R0 margin means that when the pathologist looked at the edges of the removed tissue under a microscope, they saw only healthy cells and no cancer [1][2]. Achieving this “clearance” is the surgeon’s highest priority, as it significantly reduces the risk of the cancer returning [1].

Common questions in this guide

What type of surgery is used for gallbladder cancer?
Surgeons typically perform a radical cholecystectomy. This involves removing the gallbladder, a small wedge of the surrounding liver, and nearby lymph nodes to ensure all hidden cancer cells are completely removed.
What is the Future Liver Remnant (FLR)?
The Future Liver Remnant is the amount of healthy liver tissue that will remain after a tumor is removed. If this remaining portion is too small, doctors may perform a procedure called portal vein embolization to help the healthy part of the liver grow before the main surgery.
Can I get a liver transplant for bile duct cancer?
Certain patients with perihilar cholangiocarcinoma whose tumors cannot be removed by standard surgery may qualify for a highly specialized transplant process. This requires strict eligibility, pre-transplant chemoradiation, and a preliminary surgery to ensure the cancer has not spread.
What does an R0 margin mean after surgery?
An R0 margin means that when the pathologist examined the edges of the surgically removed tissue under a microscope, they found only healthy cells and no cancer. Achieving an R0 margin is the surgeon's highest priority because it significantly lowers the risk of the cancer returning.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on the location of my tumor, what is the exact name of the surgical procedure you are recommending?
  2. 2.What is my calculated 'Future Liver Remnant' (FLR) percentage, and do I need portal vein embolization (PVE) to grow my liver before surgery?
  3. 3.If my tumor is perihilar, does our center follow the Mayo Clinic Protocol for liver transplantation?
  4. 4.How do you plan to ensure we achieve an R0 margin, and what happens if the margin comes back as R1 during the surgery?
  5. 5.Will you be performing a staging laparotomy before the main surgery or transplant to check for spread that didn't show up on scans?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant Therapies.

    Hickman L, Contreras C

    The Surgical clinics of North America 2019; (99(2)):337-355 doi:10.1016/j.suc.2018.12.008.

    PMID: 30846038
  2. 2

    Treatment of Resectable Gallbladder Cancer.

    Vega EA, Mellado S, Salehi O, et al.

    Cancers 2022; (14(6)) doi:10.3390/cancers14061413.

    PMID: 35326566
  3. 3

    Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?

    Ricci AD, Rizzo A

    Medicina (Kaunas, Lithuania) 2021; (57(12)) doi:10.3390/medicina57121301.

    PMID: 34946246
  4. 4

    T3 gallbladder cancer: surgical outcomes according to the mode of tumor spread and treatment considerations for oncological resectability.

    Kawachi Y, Sakata J, Nomura T, et al.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2025; (51(12)):110457 doi:10.1016/j.ejso.2025.110457.

    PMID: 41004864
  5. 5

    Feasibility Assessment of Robotic Major Hepatectomy and Bile Duct Resection in Klatskin Type IIIB Tumor with Concomitant Gallbladder Cancer.

    Jang EJ, Kim KW

    Annals of surgical oncology 2024; (31(12)):7898-7899 doi:10.1245/s10434-024-16006-0.

    PMID: 39112737
  6. 6

    Utilization of Multiorgan Radiomics to Predict Future Liver Remnant Hypertrophy After Portal Vein Embolization: Another Tool for the Toolbox?

    Dixon MEB, Pappas SG

    Annals of surgical oncology 2024; (31(2)):705-708 doi:10.1245/s10434-023-14659-x.

    PMID: 38062291
  7. 7

    Minimum proportion of future liver remnant in safe major hepatopancreatoduodenectomy.

    Umemura K, Shimizu A, Notake T, et al.

    Annals of gastroenterological surgery 2025; (9(1)):188-198 doi:10.1002/ags3.12850.

    PMID: 39759991
  8. 8

    Comparison of liver venous deprivation with portal vein embolization alone in patients undergoing major liver resection: a systematic review and meta-analysis.

    Yang L, Yang M, Wang T, et al.

    HPB : the official journal of the International Hepato Pancreato Biliary Association 2024; (26(11)):1329-1338 doi:10.1016/j.hpb.2024.07.409.

    PMID: 39054212
  9. 9

    Dealing with insufficient liver remnant: Associating liver partition and portal vein ligation for staged hepatectomy.

    Linecker M, Kuemmerli C, Clavien PA, Petrowsky H

    Journal of surgical oncology 2019; (119(5)):604-612 doi:10.1002/jso.25435.

    PMID: 30847941
  10. 10

    Single-center experience of liver transplantation for perihilar cholangiocarcinoma.

    Ahmed O, Vachharajani N, Chang SH, et al.

    HPB : the official journal of the International Hepato Pancreato Biliary Association 2022; (24(4)):461-469 doi:10.1016/j.hpb.2021.08.940.

    PMID: 34465528
  11. 11

    Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study.

    Hoogwater FJH, Kuipers H, de Meijer VE, et al.

    BJS open 2023; (7(2)) doi:10.1093/bjsopen/zrad025.

    PMID: 37032423

This page provides educational information about surgical options for biliary and gallbladder cancers. Always consult your surgical oncologist to determine the safest and most effective treatment plan for your specific case.

Get notified when new evidence is published on Carcinoma of gallbladder and extrahepatic biliary tract.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.